Clinical Trials Logo

Dermatologic Complication clinical trials

View clinical trials related to Dermatologic Complication.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05966779 Completed - Vascular Diseases Clinical Trials

Physical Therapy in Lipedema Surgery

Start date: July 1, 2023
Phase:
Study type: Observational

The goal of this observational study or clinical trial is to know evaluate the effects of a modified Complete Decongestive Therapy protocol using the Godoy Method in the postoperative period following lipedema surgery. The main question it aims to answer are: - if the treatment is effective on pain reduction, edema resorption, mobility improvement in short term and follow-up at 90 days - if the treatment is effective on preventing complications of these participants after surgery Participants have been treated in the lasts years and authors recover information of the effects of the treatment. Researchers will compare sub-groups of participants depending on the number of physical therapy sessions received

NCT ID: NCT04327752 Completed - Clinical trials for Gastrointestinal Disease

Skin Adverse Reactions Occuring in Children Treated by Biotherapy for Chronic Inflammatory Disease

MDEBMIC
Start date: March 12, 2020
Phase:
Study type: Observational

Biological treatments (BT) are commonly prescribed to treat chronic inflammatory diseases in children. Paradoxical reactions during treatment with a biological agent can be defined as the appearance or exacerbation of a pathological condition that usually responds to this class of drug while treating a patient for another condition. Limited data are available in children treated by BT on cutaneous paradoxical reactions, or any other cutaneous adverse events occurring during treatment. On the contrary, dermatologists tend to see and manage increasing numbers of cutaneous adverse events, including paradoxical reactions. The aim of this project is to describe the incidence of cutaneous adverse events, including cutaneous paradoxical reactions, occurring in the pediatric population, during a treatment by BT given for a chronic inflammatory disease.

NCT ID: NCT04258904 Completed - Type 1 Diabetes Clinical Trials

Prevention of Skin Problems With Diabetes Devices in Pediatric Patients

Start date: March 10, 2020
Phase: N/A
Study type: Interventional

A Cluster-controlled Intervention Trial regarding Prevention of Dermatological Complications towards use of Continuous glucose monitoring and insulin pumps in pediatric patients with Type 1 Diabetes. The patients will be followed prospectively with visits every 3rd month for the first year of initiation of device. Besides a standardized treatment plan if dermatological complications evolve, will be used.

NCT ID: NCT01867294 Completed - Clinical trials for Advanced Malignant Neoplasm

Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab

Start date: August 31, 2012
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies how well giving spironolactone works in preventing rash in patients with cancer that has spread to other places in the body and are receiving panitumumab and cetuximab. Spironolactone may prevent endothelial growth factor receptor (EGFR) inhibitor-induced skin rash.